Table 4 Wipe sample enrichment factors for ifosfamide, cyclophosphamide, and paclitaxel
Nominal concentration (μg/mL) | Recovery of concentrated spiked wipe samples (mean ± SD %) | Recovery of non-concentrated spiked wipe samples (mean ± SD %) | Ratio concentrated non-concentrated spiked wipe samples |
|---|---|---|---|
Ifosfamide | |||
5 | 1018.0 ± 0.45 | 92.0 ± 0.87 | 11.1 |
10 | 907.0 ± 1.2 | 111.0 ± 2.4 | 8.2 |
15 | 1042.0 ± 1.9 | 105.3 ± 1.7 | 9.9 |
Cyclophosphamide | |||
5 | 896.0 ± 1.3 | 108.0 ± 0.54 | 8.3 |
10 | 982.0 ± 0.32 | 96.0 ± 0.71 | 10.2 |
15 | 1009.3 ± 1.8 | 119.3 ± 1.2 | 8.5 |
Paclitaxel | |||
5 | 985.0 ± 1.4 | 98.0 ± 0.48 | 10.0 |
10 | 957.0 ± 2.7 | 115.0 ± 1.8 | 8.3 |
15 | 988.7 ± 0.12 | 105.3 ± 0.69 | 9.4 |